KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapse

Abstract
Key Points C2 confers increased susceptibility to childhood B-ALL. C2 is associated with increased risk of late relapse in childhood B-ALL.